PLUS THERAPEUTICS, INC. — Director's Dealing 2013

Feb 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-01-31

Reporting Person: CALHOUN CHRISTOPHER J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-31	Restricted Stock (Common Stock)	D	21105	—	Disposed	147270	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-31	Employee Stock Option	$2.74	A	250000	Acquired	2023-01-31	Common Stock (250000)	Direct
2013-01-31	Employee Stock Option	$5.00	A	125000	Acquired	2023-01-31	Common Stock (125000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36850	Indirect

Footnotes

F1: On January 31st, 2013 the Compensation Committee of the Board of Directors determined that 58% of the performance goals for the 2012 performance conditioned restricted stock grant were achieved, and that such percentage of shares granted will continue to time vest through January 10, 2014. The remaining portion of the 2012 performance grant shares (42%) are no longer qualified to continue vesting and have been cancelled. The disposition of these cancelled shares is reflected in Table I above.

F2: The Employee Stock options vest 1/48th each month from date of grant.